Nacuity Pharmaceuticals, Inc. is a clinical stage pharmaceutical company whose mission is to develop a breakthrough treatment for retinitis pigmentosa (“RP”) and potentially other ophthalmological indications. Our lead technology is based on studies from the laboratory of Dr. Peter Campochiaro at the Wilmer Eye Institute involving oxidative stress in the retina.
Nacuity has assembled an accomplished team and has received ...
Nacuity Pharmaceuticals, Inc. is a clinical stage pharmaceutical company whose mission is to develop a breakthrough treatment for retinitis pigmentosa (“RP”) and potentially other ophthalmological indications. Our lead technology is based on studies from the laboratory of Dr. Peter Campochiaro at the Wilmer Eye Institute involving oxidative stress in the retina.
Nacuity has assembled an accomplished team and has received significant financial and technical support from the Foundation Fighting Blindness (FFB).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.